IMUGENE CHART. TA only, page-12052

I’m trying to take @Owl vs Fox advice and not be harsh on newbies but when you have over 13,000 posts I reckon you’re fair game. Sorry Foxy.

He talks the talk as though he’s an experienced investor and yet puts his investment capital into the middle of a huge downtrend. Strike 1.

So you’ve mentioned a few times today that IMU is a start-up bio company. Mate IMU was a start up when the SP was under 1 cent when many here put there funds in and crossed everything because at the time there wasn’t even a trial in sight. Huge risk on our capital at the time. Over the next few years, many announcements, many developments, many acquisitions, many strong staff recruitments and a few startling results from the labs transitioned the company from a “start- up” to a serious cancer research arm plus owning products that may make significant impact on cancer patients down the track.
Have you even considered who IMU are now linked with and where they are positioned? So for you to label it a “start-up” is a complete joke and proves your research inabilities. Strike 2.

And then to come onto a TA only thread and pepper the pages with how you think TA is useless on this stock (an ASX200 stock) is just laughable and proves you fail on all counts. Strike 3.

You would die if you saw the amount of trades I’ve closed on this glorious stock.

Dare I say it, there’s a “rubbing my ball thread” thread for you cause you’ve got nothing to add here.

Foxy, that’s me being nice. (Should have seen the first draft)

Cheers.